Genetesis

Genetesis: A medical imaging company bridging state of the art data science and biomagnetism to win the fight against cardiovascular disease

Visit Genetesis Website
Genetesis

"TDK’s rich history in magnetics and its recent breakthroughs in biomagnetics at picoTesla levels makes them one of our strongest partners to date. We are committed to bring the most accurate diagnostics that can assist emergency physicians and cardiologists in making the best decisions for cardiac health in a non-invasive and a rapid fashion. We are elated to have TDK as our strategic partner because of their pioneering work in magnetic materials and its commercialization. Their recent leadership around supporting frontier-tech entrepreneurs caught our attention and we are excited about this next chapter."

  • Peeyush Shrivastava
  • Founder and CEO, Genetesis

Portfolio News

TDK Ventures Invests in Biomagnetic Medical Imaging Company Genetesis

TDK Ventures invests in Genetesis, pioneering non-invasive cardiac diagnostics with cutting-edge biomagnetic imaging technology.

TDK Ventures Closes $150 Million Fund for Early-Stage, Materials Science and Hard-Tech Startups

TDK Ventures launches Fund II with $150 million to invest in transformative tech startups in clean tech and advanced materials.

Media Coverage

Stories From Other Sources

FDA Awards Genetesis Breakthrough Device Designation for CardioFlux® Imaging Technology

Dec 15, 2020

Cardiac Imaging Company Genetesis Adds TDK Ventures as Strategic Investor and Welcomes New Board Member

May 07, 2020

Supporting Team

  • Engagement

Geetha Dholakia

Portfolio Program Director
  • Fund EX1

Anil Achyuta

Investment Managing Director